Terms: = Liver cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
1784 results:
1. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Utility of Cytokeratins for Accurate diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract] [Full Text] [Related]
3. Tyrosine hydroxylase inhibits HCC progression by downregulating TGFβ/Smad signaling.
Liu G; Li M; Zeng Z; Fan Q; Ren X; Wang Z; Sun Y; He Y; Sun L; Deng Y; Liu S; Zhong C; Gao J
Eur J Med Res; 2024 Apr; 29(1):228. PubMed ID: 38610044
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
5. Placental metastasis from maternal NUT carcinoma: diagnostic pitfalls and challenges.
Lai JK; Panasci L; Patey NG; Wang H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569728
[TBL] [Abstract] [Full Text] [Related]
6. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
7. A simple, rapid and sensitive sandwich immunoassay based on poly(N-isopropylacrylamide) for the detection of alpha-fetoprotein.
Zhang Y; Yi K; Gong F; Tang Z; Feng Y; Tian Y; Xiang M; Zhou F; Liu M; Ji X; He Z
Talanta; 2024 Jul; 274():125932. PubMed ID: 38537351
[TBL] [Abstract] [Full Text] [Related]
8. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
Dai S; Zhu J; Chen X; Zheng L; Li X; Liu L
J Cancer Res Clin Oncol; 2024 Mar; 150(3):157. PubMed ID: 38528272
[TBL] [Abstract] [Full Text] [Related]
9. Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI.
Zhang ZX; Xv H; Du YN; Lv ZB; Yang ZH
BMC Gastroenterol; 2024 Mar; 24(1):117. PubMed ID: 38515017
[TBL] [Abstract] [Full Text] [Related]
10. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
[No Abstract] [Full Text] [Related]
11. Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma.
Jiang D; Zhu XL; An Y; Li YR
PeerJ; 2024; 12():e16876. PubMed ID: 38500533
[TBL] [Abstract] [Full Text] [Related]
12. Ratiometric electrochemical immunoassay based on 2D Co/Fe MOF decorated with toluidine blue and Fc-labeled Schiff base for accurate assay of alpha-fetoprotein in clinical serum.
Sun HN; Wang M; Tan HS; Liu HP; Liu M; Li SS
Talanta; 2024 Jun; 273():125876. PubMed ID: 38458082
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
Kaneko S; Asahina Y; Murakawa M; Azuma S; Inada K; Mochida T; Watakabe K; Shimizu T; Tsuchiya J; Miyoshi M; Kawai-Kitahata F; Nitta S; Takahashi M; Fujioka T; Kishino M; Anzai T; Kakinuma S; Nakagawa M; Okamoto R
PLoS One; 2024; 19(3):e0297882. PubMed ID: 38452155
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of survival and analysis of prognostic factors for patients with afp negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
15. Clinical outcomes of percutaneous microwave ablation for pulmonary oligometastases from hepatocellular carcinoma: a retrospective, multicenter study.
Wang G; Wei Z; Wang F; Han X; Jia H; Zhao D; Li C; Liu L; Yang X; Ye X
Cancer Imaging; 2024 Mar; 24(1):34. PubMed ID: 38438879
[TBL] [Abstract] [Full Text] [Related]
16. Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study.
Lin KY; Zhang JX; Lin ZW; Chen QJ; Luo LP; Chen JH; Wang K; Tai S; Zhang ZB; Wang SF; Li JD; Wang K; Zheng L; Zheng SM; Wu MM; Lin KC; Yang T; Zeng YY
Front Immunol; 2024; 15():1308543. PubMed ID: 38433845
[TBL] [Abstract] [Full Text] [Related]
17. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis.
Nan Y; Garay OU; Lu X; Zhang Y; Xie L; Niu Z; Chen W
J Comp Eff Res; 2024 Apr; 13(4):e230146. PubMed ID: 38415341
[No Abstract] [Full Text] [Related]
18. Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at diagnosis of Hepatocellular Carcinoma.
Gil-Rojas S; Suárez M; Martínez-Blanco P; Torres AM; Martínez-García N; Blasco P; Torralba M; Mateo J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396674
[TBL] [Abstract] [Full Text] [Related]
19. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients.
Sukaram T; Tansawat R; Phathong C; Rerknimitr R; Chaiteerakij R
Clin Chim Acta; 2024 Mar; 556():117831. PubMed ID: 38378104
[TBL] [Abstract] [Full Text] [Related]
20. An AgPd NP-based lateral flow immunoassay for simultaneous detection of glycocholic acid and alpha-fetoprotein.
Jiang S; Chen Y; Liang J; Xiao H; Lin M; Cui X; Zhao S
Anal Methods; 2024 Mar; 16(10):1508-1514. PubMed ID: 38372146
[TBL] [Abstract] [Full Text] [Related]
[Next]
